MPD: Phenotype measures mapped to VT:0008037, T cell morphology trait

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.

Phenotype measures associated with ontology term
VT:0008037 'T cell morphology trait'

All measures in this list are mapped to the ontology descendants of VT:0008037. None are mapped to VT:0008037 directly.

VT:0001830 effector T cell quantity
VT:0004972 regulatory T cell quantity
VT:0005089 double-negative T cell quantity
VT:0006387 T cell quantity
VT:0008038 NK T cell quantity
VT:0008073 CD4-positive T cell quantity
VT:0008077 CD8-positive T cell quantity
VT:0008345 gamma-delta T cell quantity
VT:0008397 CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology trait

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Benoist1:1	Benoist1	immune cell quantification	(none)	percentage of thymic CD4 Treg cells that are CD25^hi [%] Treg_thy_CD25 25801	inbred	33	m	5-6wks	N=3	2007

Benoist1:2	Benoist1	immune cell quantification	(none)	percentage of thymic CD4 Treg cells that are Foxp3+ [%] Treg_thy_Foxp3 25802	inbred	10	m	5-6wks	N=3	2007

Benoist1:3	Benoist1	immune cell quantification	(none)	percentage of splenic CD4 Treg cells that are CD25^hi [%] Treg_spl_CD25 25803	inbred	31	m	5-6wks	N=3	2007

Benoist1:4	Benoist1	immune cell quantification	(none)	percentage of splenic CD4 Treg cells that are Foxp3+ [%] Treg_spl_Foxp3 25804	inbred	10	m	5-6wks	N=3	2007

Donahue5:9	Donahue5	immune cell quantification	(none)	T cells (percentage of viable WBC) [%] pct_T_cells 41409	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:10	Donahue5	immune cell quantification	(none)	CD4 T cells (percentage of viable WBC) [%] pct_CD4 41410	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue5:12	Donahue5	immune cell quantification	(none)	CD8 T cells (percentage of viable WBC) [%] pct_CD8 41412	B6.A consomic w/par	22	both	7wks	N=8	2011

Donahue6:9	Donahue6	immune cell quantification	(none)	T cells (percentage of viable WBC) [%] pct_T_cells 41509	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:10	Donahue6	immune cell quantification	(none)	CD4 T cells (percentage of viable WBC) [%] pct_CD4 41510	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Donahue6:11	Donahue6	immune cell quantification	(none)	CD8 T cells (percentage of viable WBC) [%] pct_CD8 41511	B6.PWD consomic w/par	28	both	7wks	N=8	2011

Farmer1:34	Farmer1	immune cell quantification	(none)	percentage of viable CD4⁺ T cells in 150 µl collected blood [%] CD4 11334	QTL population		both	6wks	N=206	2001

Farmer1:35	Farmer1	immune cell quantification	(none)	percentage of viable CD8⁺ T cells in 150 µl collected blood [%] CD8 11335	QTL population		both	6wks	N=206	2001

Graham1:29	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD4+ in brain, post infection [%] CD4_brain 63329 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:33	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD4+ in spleen, post infection [%] CD4_spleen 63333 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:37	Graham1	immune cell quantification	West Nile virus	percentage of CD4+ T cells that are Foxp3+ in the brain, post infection [%] Treg_brain 63337 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:41	Graham1	immune cell quantification	West Nile virus	percentage of CD4+ T cells that are Foxp3+ in the spleen, post infection [%] Treg_spleen 63341 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:45	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD8+ in brain, post infection [%] CD8_brain 63345 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:49	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are CD8+ in spleen, post infection [%] CD8_spleen 63349 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham1:53	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are NS4b+ in brain, post infection [%] NS4b_brain 63353 day 7 day 12 day 21 day 28	CC RIX	5	m	8-10wks	N=3	2015

Graham1:57	Graham1	immune cell quantification	West Nile virus	percentage of CD3+ T cells that are NS4b+ in spleen, post infection [%] NS4b_spleen 63357 day 7 day 12 day 21 day 28	CC RIX	2	m	8-10wks	N=3	2015

Graham3:9	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_tot 113800	CC RIX	102	m	8-10wks	N=4	2021

Graham3:10	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Foxp3+ (Treg) [%] Tregs 113801	CC RIX	102	m	8-10wks	N=4	2021

Graham3:11	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD29+ [%] Treg_CD29_pos 113802	CC RIX	102	m	8-10wks	N=4	2021

Graham3:12	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD44hi [%] Treg_CD44_hi 113803	CC RIX	102	m	8-10wks	N=4	2021

Graham3:13	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CD73+ [%] Treg_CD73_pos 113804	CC RIX	102	m	8-10wks	N=4	2021

Graham3:14	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CTLA-4+ [%] Treg_CTLA4_pos 113805	CC RIX	102	m	8-10wks	N=4	2021

Graham3:15	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are CXCR3+ [%] Treg_CXCR3_pos 113806	CC RIX	102	m	8-10wks	N=4	2021

Graham3:16	Graham3	immune cell quantification	(none)	percentage of splenic Treg cells that are ICOS+ (inducible costimulator) [%] Treg_ICOS_pos 113807	CC RIX	102	m	8-10wks	N=4	2021

Graham3:21	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells (memory precursor panel) [%] mp_CD3_pos 113812	CC RIX	92	m	8-10wks	N=4	2021

Graham3:22	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ (memory precursor panel) [%] mp_CD3_pos_CD8_pos 113813	CC RIX	92	m	8-10wks	N=4	2021

Graham3:23	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD44+ (memory precursor panel) [%] mp_CD8_pos_CD44_pos 113814	CC RIX	91	m	8-10wks	N=4	2021

Graham3:24	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD62L- (memory precursor panel) [%] mp_CD8_pos_CD62L_neg 113815	CC RIX	76	m	8-10wks	N=3	2021

Graham3:25	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are Ki67+ (memory precursor panel) [%] mp_CD8_pos_Ki67_pos 113816	CC RIX	92	m	8-10wks	N=4	2021

Graham3:26	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ (memory precursor panel) [%] mp_CD3_pos_CD4_pos 113817	CC RIX	92	m	8-10wks	N=4	2021

Graham3:27	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD44+ (memory precursor panel) [%] mp_CD4_pos_CD44_pos 113818	CC RIX	91	m	8-10wks	N=4	2021

Graham3:28	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD62L- (memory precursor panel) [%] mp_CD4_pos_CD62L_neg 113819	CC RIX	73	m	8-10wks	N=3	2021

Graham3:29	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Ki67+ (memory precursor panel) [%] mp_CD4_pos_Ki67_pos 113820	CC RIX	92	m	8-10wks	N=4	2021

Graham3:34	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells (memory panel) [%] mem_CD3_pos 113825	CC RIX	68	m	8-10wks	N=3	2021

Graham3:35	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ (memory panel) [%] mem_CD3_pos_CD8_pos 113826	CC RIX	68	m	8-10wks	N=3	2021

Graham3:36	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD44+ (memory panel) [%] mem_CD8_pos_CD44_pos 113827	CC RIX	73	m	8-10wks	N=3	2021

Graham3:37	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are CD62L- (memory panel) [%] mem_CD8_pos_CD62L_neg 113828	CC RIX	68	m	8-10wks	N=3	2021

Graham3:38	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are Ki67+ (memory panel) [%] mem_CD8_pos_Ki67_pos 113829	CC RIX	73	m	8-10wks	N=3	2021

Graham3:39	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ (memory panel) [%] mem_CD3_pos_CD4_pos 113830	CC RIX	68	m	8-10wks	N=3	2021

Graham3:40	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD44+ (memory panel) [%] mem_CD4_pos_CD44_pos 113831	CC RIX	73	m	8-10wks	N=3	2021

Graham3:41	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are CD62L- (memory panel) [%] mem_CD4_pos_CD62L_neg 113832	CC RIX	68	m	8-10wks	N=3	2021

Graham3:42	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Ki67+ (memory panel) [%] mem_CD4_pos_Ki67_pos 113833	CC RIX	73	m	8-10wks	N=3	2021

Graham3:47	Graham3	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD3+ T cells following stimulation with anti-CD3 and anti CD28 [%] ics_CD3_pos 113838	CC RIX	102	m	8-10wks	N=4	2021

Graham3:48	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD8+ following stimulation with anti-CD3 and anti-CD28 [%] ics_CD3_pos_CD8_pos 113839	CC RIX	102	m	8-10wks	N=4	2021

Graham3:49	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are IL-17+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD8_pos_IL17_pos 113840	CC RIX	102	m	8-10wks	N=4	2021

Graham3:50	Graham3	immune cell quantification	(none)	percentage of splenic CD8+ T cells that are IFNg+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD8_pos_IGNg_pos 113841	CC RIX	102	m	8-10wks	N=4	2021

Graham3:51	Graham3	immune cell quantification	(none)	percentage of splenic CD3+ T cells that are CD4+ following stimulation with anti-CD3 and anti-CD28 [%] ics_CD3_pos_CD4_pos 113842	CC RIX	102	m	8-10wks	N=4	2021

Graham3:52	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are IL-17+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_IL17_pos 113843	CC RIX	102	m	8-10wks	N=4	2021

Graham3:53	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are IFNg+ by intracellular cytokine staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_IFNg_pos 113844	CC RIX	102	m	8-10wks	N=4	2021

Graham3:54	Graham3	immune cell quantification	(none)	percentage of splenic CD4+ T cells that are Tbet+ (transcription factor) by intracellular staining following stimulation with anti-CD3 and anti-CD28 [%] ics_CD4_pos_Tbet_pos 113845	CC RIX	92	m	8-10wks	N=4	2021

Hackstein1:14	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ T cells (percentage of CD45+ cells) [%] T_CD3 49114	inbred	5	m	7-11wks	N=9	2012

Hackstein1:15	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD8+ T cells (percentage of CD45+ cells) [%] T_CD8 49115	inbred	5	m	7-11wks	N=9	2012

Hackstein1:16	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ T cells (percentage of CD45+ cells) [%] T_CD4 49116	inbred	5	m	7-11wks	N=9	2012

Hackstein1:17	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25+ T cells (percentage of CD45+ cells) [%] T_CD4_25 49117	inbred	5	m	7-11wks	N=8	2012

Hackstein1:18	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25^hi Treg cells (percentage of CD45+ cells) [%] T_CD4_25hi 49118	inbred	5	m	7-11wks	N=5	2012

Hackstein1:19	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25^hi Foxp3+ Treg cells (percentage of CD45+ cells) [%] T_CD4_foxp3 49119	inbred	5	m	7-11wks	N=5	2012

Hackstein1:20	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ CD4+ CD25^hi Foxp3+ CD39+ Treg cells (percentage of CD45+ cells) [%] T_CD4_39 49120	inbred	5	m	7-11wks	N=5	2012

Hackstein1:21	Hackstein1	immune cell quantification	(none)	bronchoalveolar lavage CD3+ gamma-delta T cells (percentage of CD45+ cells) [%] T_gd 49121	inbred	5	m	7-11wks	N=9	2012

Jaxpheno6:1	Jaxpheno6	immune cell quantification	(none)	splenic CD4 T cells (percentage of total viable cells) [%] pct_CD4 23101 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:3	Jaxpheno6	immune cell quantification	(none)	splenic CD8 T cells (percentage of total viable cells) [%] pct_CD8 23103 8wks 16wks	inbred	11	both		N=9	2006

Jaxpheno6:5	Jaxpheno6	immune cell quantification	(none)	splenic NK T cells (percentage of total viable cells) [%] pct_NKT 23105 8wks 16wks	inbred	11	both		N=9	2006

Lesage1:10	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are NK T cells (TCRb+ CD1d+) [%] NKT_cells 63510	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:11	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_NKT 63511	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:12	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ NK T cells [%] CD4_pos_CD8_neg_NKT_of_tot 63512	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:13	Lesage1	immune cell quantification	(none)	percentage of splenic NK T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_NKT 63513	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:14	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- NK T cells [%] CD4_neg_CD8_neg_NKT_of_tot 63514	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:15	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are T cells [%] T_cells 63515	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:16	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4+ CD8- [%] CD4_pos_CD8_neg_of_Tcells 63516	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:17	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4+ T cells [%] CD4_pos_CD8_neg_of_tot 63517	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:18	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8+ [%] CD4_neg_CD8_pos_of_Tcells 63518	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:19	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD8+ T cells [%] CD4_neg_CD8_pos_of_tot 63519	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:20	Lesage1	immune cell quantification	(none)	percentage of splenic T cells that are CD4- CD8- [%] CD4_neg_CD8_neg_of_Tcells 63520	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:21	Lesage1	immune cell quantification	(none)	percentage of splenic lymphocytes that are CD4- CD8- T cells [%] CD4_neg_CD8_neg_of_tot 63521	CC w/par	76	both	5-8wks	N=2	2018

Lesage1:22	Lesage1	immune cell quantification	(none)	ratio of splenic CD4+ to CD8+ T cells [ratio] CD4_CD8_ratio 63522	CC w/par	76	both	5-8wks	N=2	2018

Petkova1:29	Petkova1	immune cell quantification	(none)	CD4 T cells, as percentage of total lymphocytes [%] CD4_all 24229 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:33	Petkova1	immune cell quantification	(none)	CD4 T cells, naive, as percentage of total CD4 T cells [%] CD4_naive 24233 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:37	Petkova1	immune cell quantification	(none)	CD4 T cells, central memory, as percentage of total CD4 T cells [%] CD4_mem_central 24237 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:41	Petkova1	immune cell quantification	(none)	CD4 T cells, effector memory, as percentage of total CD4 T cells [%] CD4_mem_effector 24241 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:46	Petkova1	immune cell quantification	(none)	CD4 T cells, effector, as percentage of total CD4 T cells [%] CD4_effector 24246 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:51	Petkova1	immune cell quantification	(none)	CD8 T cells, as percentage of total lymphocytes [%] CD8_all 24251 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:56	Petkova1	immune cell quantification	(none)	CD8 T cells, naive, as percentage of total CD8 T cells [%] CD8_naive 24256 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:61	Petkova1	immune cell quantification	(none)	CD8 T cells, central memory, as percentage of total CD8 T cells [%] CD8_mem_central 24261 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:66	Petkova1	immune cell quantification	(none)	CD8 T cells, effector memory, as percentage of total CD8 T cells [%] CD8_mem_effector 24266 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:71	Petkova1	immune cell quantification	(none)	CD8 T cells, effector, as percentage of total CD8 T cells [%] CD8_effector 24271 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Williams1:1	Williams1	immune cell quantification	(none)	CD4 Treg cells (CD25+ CD44^int; as percentage of lymphocytes) [%] Treg 42901	inbred	5	f	8wks	N=3	2012

Williams1:2	Williams1	immune cell quantification	(none)	CD4 Treg cells (CD25+ CD44^int; as percentage of CD4 T cells) [%] Treg_adj 42902	inbred	5	f	8wks	N=3	2012

Williams1:3	Williams1	immune cell quantification	(none)	memory-effector CD4 T cells (CD25^- CD44^hi; as percentage of lymphocytes) [%] memoryT 42903	inbred	5	f	8wks	N=3	2012

Williams1:4	Williams1	immune cell quantification	(none)	memory-effector CD4 T cells (CD25^- CD44^hi; as percentage of CD4 T cells) [%] memoryT_adj 42904	inbred	5	f	8wks	N=3	2012

Williams1:5	Williams1	immune cell quantification	(none)	naive CD4 T cells (CD25^- CD44^lo; as percentage of lymphocytes) [%] naiveT 42905	inbred	5	f	8wks	N=3	2012

Williams1:6	Williams1	immune cell quantification	(none)	naive CD4 T cells (CD25^- CD44^lo; as percentage of CD4 T cells) [%] naiveT_adj 42906	inbred	5	f	8wks	N=3	2012

Wiltshire4:7	Wiltshire4	immune cell quantification	BEZ235	T cells, percent viability [%] Tcells_BEZ 52407 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

Wiltshire4:27	Wiltshire4	immune cell quantification	doxorubicin	T cells, percent viability [%] Tcells_Dox 52427 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:47	Wiltshire4	immune cell quantification	idarubicin	T cells, percent viability [%] Tcells_Ida 52447 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	35	m	10wks	N=4	2015

Wiltshire4:67	Wiltshire4	immune cell quantification	selumetinib	T cells, percent viability [%] Tcells_Sel 52467 dose [µM]: control 0.046 0.137 1.235 11.1 100	inbred w/CC7	34	m	10wks	N=4	2015

An error occurred on this page.These results could be incomplete or invalid. Staff have been notified.

Filter Table Results

An error occurred on this page.
These results could be incomplete or invalid. Staff have been notified.